ArticleMedicine2026
PFAS exposure and hypertension in US adults: A multi-method, cross-sectional analysis of NHANES 2005 to 2014.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Per- and polyfluoroalkyl substances (PFAS) are persistent environmental contaminants, but evidence linking PFAS exposure to hypertension remains limited and inconsistent. We analyzed 5 contiguous National Health and Nutrition Examination Survey cycles (2005-2014), including 6644 adults. Associations with hypertension were estimated by multivariable logistic regression. Restricted cubic splines and piecewise threshold models assessed nonlinearity. Mixture effects were examined using weighted quantile sum and quantile g-computation (Q-gcomp). Eight machine-learning classifiers were compared using cross-validated AUC. XGBoost was selected as the final model and interpreted with SHAP. In continuous multivariable models, PFOA (OR, 1.04, 95% CI, 1.00-1.08, P = .036) and PFOS (OR, 1.04, 95% CI, 1.01-1.07, P = .007) were positively associated with hypertension; Me-PFOSA-AcOH showed a marginal positive association (OR, 1.07, 95% CI, 1.00-1.14, P = .045). Quartile analyses showed elevated odds for PFOA and for PFOS. Spline and threshold models identified compound-specific inflection points with differential associations below versus above cutpoints. Weighted quantile sum positive-direction index was modestly associated with hypertension (OR, 1.13, 95% CI, 1.03-1.26, P = .01) with PFUA contributing most; q-gcomp results were concordant. XGBoost achieved the highest discrimination (AUC = 0.814); SHAP ranked PFOS, PFNA and PFOA as leading predictors by mean SHAP. Specific PFAS were associated with prevalent hypertension, and PFAS mixtures showed a modest joint effect. Machine-learning and SHAP analysis highlighted specific congeners driving predictive signal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.